Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 64 | 46 | 54 | 54 | 48 |
| Accounts receivable | 376 | -26 | -325 | -10 | -219 |
| Other Working Capital | -4,775 | -110 | -1,096 | 146 | -457 |
| Other Operating Activity | 3,916 | -449 | -802 | -1,174 | -163 |
| Operating Cash Flow | $-420 | $-538 | $-2,169 | $-984 | $-790 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -5 | -10 | -5 | 55 |
| Net Acquisitions | 73 | 0 | 9,569 | N/A | N/A |
| Purchase Sale Intangibles | -37 | -3 | -23 | -2 | -1 |
| Other Investing Activity | 0 | 0 | -491 | -3 | -66 |
| Investing Cash Flow | $32 | $-8 | $9,044 | $-10 | $-12 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -6,154 | -154 | -6,153 | -193 | -258 |
| Common Stock Issued | 0 | 0 | N/A | N/A | 1 |
| Other Financing Activity | 6,357 | 235 | -1,416 | 1,003 | 1,325 |
| Financing Cash Flow | $203 | $81 | $-7,569 | $810 | $1,068 |
| Beginning Cash Position | 544 | 1,010 | 827 | 749 | 1,623 |
| End Cash Position | 359 | 544 | 1,010 | 827 | 749 |
| Net Cash Flow | $-1,325 | $-466 | $-694 | $-185 | $266 |
| Free Cash Flow | |||||
| Operating Cash Flow | -420 | -538 | -2,169 | -984 | -790 |
| Capital Expenditure | -41 | -8 | -33 | -7 | N/A |
| Free Cash Flow | -461 | -547 | -2,202 | -991 | -790 |